Triomics has raised $22M in Series B funding to expand its AI platform that helps cancer centers automate data-heavy tasks like clinical trial matching and appointment preparation. The platform uses large language models to create verifiable patient summaries, reducing administrative burden on oncology staff. The funding round was led by Battery Ventures with participation from existing investors including Nexus Venture Partners and Lightspeed.
Background
The increasing complexity of cancer patient records, often spanning thousands of pages, has created significant administrative challenges for oncology practices. AI solutions are emerging to help healthcare providers manage this data deluge more efficiently.
- Source
- TechCrunch
- Published
- May 28, 2026 at 05:11 AM
- Score
- 7.0 / 10